Accreditation Information

    Direct Accreditation:

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Objectives

At the conclusion of the lecture participants will be able to:
1. Apply risk stratification to sudden cardiac death risk in hypertrophic cardiomyopathy
2. Identify cardiac imaging risk factors for sudden cardiac death in hypertrophic cardiomyopathy

Target Audience

Cardiovascular staff and fellows in training

Faculty Disclosure

Faculty, Planning Committee and CME Administrator disclosure statement

Martin Maron, Speaker,  has no relevant financial relationships to disclose

Michael Klein, Course Director, has no relevant financial relationships to disclose

Sakina Flint, RSS Coordinator, has no relevant financial relationships to disclose

Faculty Disclosure of off-label use

Faculty member plan on discussing unlabeled/investigational uses of a Gadolinium product.

Faculty Disclosure Policy

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.